Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
NITAG documentation
2021
Background paper
Clear all
Type of publications
NITAG documentation
(27)
Topics
Background paper
(27)
Regions
Americas
(26)
Europe
(1)
Countries
Diseases
COVID-19
(27)
Vaccine topics
Target population
Methodological quality (AMSTAR 2)
Publication date
2021
(27)
2022
(9)
2020
(48)
2019
(2)
2018
(1)
2017
(1)
Available to download in languages
English (EN)
(27)
27 results found
2021
∙
ACIP
Adverse events among children ages 5–11 years after COVID-19 vaccination: updates from v-safe and the Vaccine Adverse Event Reporting System (VAERS)
2021
∙
ACIP
COVID-19 Vaccine Safety Technical (VaST) Work Group
2021
∙
ACIP
Update on Omicron Variant
2021
∙
ACIP
Updates on Thrombosis with Thrombocytopenia Syndrome (TTS)
2021
∙
ACIP
Updates to the benefit/risk assessment for Janssen COVID-19 vaccines
2021
∙
ACIP
ACIP Evidence to Recommendations for Use of Janssen COVID-19 Vaccine under an Emergency Use Authorization
2021
∙
Sara Oliver, ACIP
ACIP Work Group interpretations of data
2021
∙
ACIP
AstraZeneca COVID-19 vaccine (AZD1222)
2021
∙
Fleming-Dutra, K. E., ACIP
CDC plans for COVID-19 vaccine effectiveness evaluation post-authorization and post-licensure
2021
∙
Public Health England
comparison between 1 and 2 dose prioritisation for a fixed number of doses
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register